September/October 2025 Supplement

Visionary Breakthroughs

A Spotlight on Innovations in Eye Care

The Ophthalmic EvidenceEngine

Using AI to bridge gaps in ophthalmic healthcare data and improve patient outcomes.

Ben Toker, Co-Founder and President, Amaros

The OmniVu^™ Lens System

Atia Vision designs a “no-compromise” PC-IOL.

Mariam Maghribi, PhD, President and CEO, Atia Vision

Corneal Endothelial Cell Therapy

An injectable cell therapy poised to rewrite the transplant playbook.

Arnaud Lacoste, MBA, PhD, CEO and Chief Scientific Officer, and Eris P. Jordan, OD, Chief Development Officer, Aurion Biotech

Eyelid Rx With AZR-MD-001

A new keratolytic with the potential to break the blockade of meibomian gland dysfunction.

Marc Gleeson, CEO, Azura Ophthalmics Pty Ltd

EndoArt®: Artificial Endothelial Implant

“The easy solution for complicated corneas.”

Ofer Daphna, MD, Inventor &, Chief Medical Officer, EyeYon Medical

The AlloFlo^™ Uveo

Unlocking the uveoscleral pathway post-MIGS.

Adam Szaronos, CEO, Iantrek

AquaLumen™ for IOP Management

Advancing the continuum between MIGS and filtration surgery.

Alvaro Luque, CEO, PLU Ophthalmic

The SpyGlass Pharma™ Drug Delivery Platform

Drug delivery integrated into the cataract surgery workflow.

Patrick Mooney, CEO, and Malik Kahook, MD, Co-Founder and Executive Chair of the Board, SpyGlass Pharma™

BRIMOCHOL^™ PF for Presbyopia

A synergistic, next-generation therapeutic for presbyopia.

Ben Bergo, Chief Business Officer, Tenpoint Therapeutics

FLIGHT: Femtosecond Laser Image-Guided High-Precision Trabeculotomy

An incision-free approach to interventional glaucoma management.

Shawn O’Neil, CEO, ViaLase